publication venue for
- Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.. 205:61-73. 2024
- Genetic testing in privately insured women with surgically treated breast cancer.. 198:177-181. 2022
- Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors.. 195:141-152. 2022
- Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.. 194:413-422. 2022
- Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy.. 194:113-126. 2022
- Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017.. 193:695-705. 2022
- Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.. 191:459-469. 2021
- Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors.. 190:287-293. 2021
- Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.. 189:521-532. 2021
- Correction to: Mammography use and breast cancer incidence among older U.S. women.. 187:-. 2021
- Mammography use and breast cancer incidence among older U.S. women.. 188:307-316. 2021
- Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer.. 184:965-975. 2020
- Factors associated with falls in older women with breast cancer: the use of a brief geriatric screening tool in clinic.. 184:445-457. 2020
- Patient preferences for locoregional therapy in early-stage breast cancer.. 183:291-309. 2020
- Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States.. 178:419-426. 2019
- Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy.. 176:261-270. 2019
- Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study.. 176:181-189. 2019
- Impact of preexisting mental illness on breast cancer endocrine therapy adherence.. 174:197-208. 2018
- Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.. 171:325-334. 2018
- Physician peer group characteristics and timeliness of breast cancer surgery.. 170:657-665. 2018
- Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).. 166:793-808. 2017
- Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).. 165:677-686. 2017
- Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer.. 164:515-525. 2017
- Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).. 164:107-117. 2017
- Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).. 163:391-398. 2017
- Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).. 161:363-373. 2016
- Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins.. 160:291-296. 2016
- Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.. 158:139-148. 2016
- Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach.. 155:223-34. 2016
- Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.. 160:547-562. 2016
- Geographic access and age-related variation in chemotherapy use in elderly with metastatic breast cancer.. 149:199-209. 2014
- Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival.. 146:411-9. 2014
- Older women's experience with breast cancer treatment decisions.. 145:211-23. 2014
- Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.. 141:261-8. 2013
- Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.. 141:155-63. 2013
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.. 139:607-16. 2013
- Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.. 138:879-87. 2013
- The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS.. 129:909-17. 2011
- Accuracy of self-reported breast cancer among women undergoing mammography.. 118:583-92. 2009